SCIASCIA, Savino
Dettaglio
SCIASCIA, Savino
SCIENZE CLINICHE E BIOLOGICHE
Pubblicazioni
Risultati 1 - 20 di 250 (tempo di esecuzione: 0.001 secondi).
Titolo | Data di pubblicazione | Autore(i) | |
---|---|---|---|
1 | 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends | 2014 | Bertolaccini, Maria Laura; Amengual, Olga; Andreoli, Laura; Atsumi, Tatsuya; Chighizola, Cecilia B.; Forastiero, Ricardo; de Groot, Philip; Lakos, Gabriella; Lambert, Marc; Meroni, Pierluigi; Ortel, Thomas L.; Petri, Michelle; Rahman, Anisur; Roubey, Robert; Sciascia, Savino; Snyder, Melissa; Tebo, Anne E.; Tincani, Angela; Willis, Rohan |
2 | 16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome | 2021 | Sciascia S.; Radin M.; Cecchi I.; Levy R.A.; Erkan D. |
3 | 16th International Congress on Antiphospholipid Antibodies Task Force Report on Obstetric Antiphospholipid Syndrome | 2020 | de Jesus G.R.; Benson A.E.; Chighizola C.B.; Sciascia S.; Branch D.W. |
4 | A 3-Year Observational Study of Patients with Progressive Systemic Sclerosis Treated with an Intensified B Lymphocyte Depletion Protocol: Clinical and Immunological Response | 2021 | Rossi, Daniela; Sciascia, Savino; Cecchi, Irene; Saracco, Marta; Montabone, Erika; Modena, Vittorio; Pellerito, Raffaele; Carignola, Renato; Roccatello, Dario |
5 | A 4 Plus 2 Infusion Protocol of Rituximab Provides Long-Term Beneficial Effects in Patients with HCV-Associated Mixed Cryoglobulinemia with Membranoproliferative Nephritis and Severe Polyneuropathy. | 2012 | Roccatello, D; Sciascia, S; Baldovino, S; Rossi, D |
6 | The "4 plus 2" rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study | 2017 | Roccatello, Dario; Sciascia, Savino; Rossi, Daniela; Alpa, Mirella; Naretto, Carla; Radin, Massimo; Fenoglio, Roberta; Baldovino, Simone; Menegatti, Elisa |
7 | A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment-Clinical response compared to literature and immunological re-assessment | 2015 | Roccatello, Dario; Sciascia, Savino; Baldovino, Simone; Rossi, Daniela; Alpa, Mirella; Naretto, Carla; Di Simone, Debora; Simoncini, Matteo; Menegatti, Elisa |
8 | 8-Isoprostane, prostaglandin E2, C-reactive protein and serum amyloid A as markers of inflammation and oxidative stress in antiphospholipid syndrome: a pilot study. | 2012 | Sciascia S; Roccatello D; Bertero MT; Di Simone D; Cosseddu D; Vaccarino A; Bazzan M; Rossi D; Garcia-Fernandez C; Ceberio L; Stella S; Menegatti E; Baldovino S. |
9 | Acute kidney injury associated with glomerular diseases | 2019 | Fenoglio R.; Sciascia S.; Baldovino S.; Roccatello D. |
10 | The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort | 2019 | Radin M.; Sciascia S.; Erkan D.; Pengo V.; Tektonidou M.G.; Ugarte A.; Meroni P.; Ji L.; Belmont H.M.; Cohen H.; Ramires de Jesus G.; Branch D.W.; Fortin P.R.; Andreoli L.; Petri M.; Rodriguez E.; Rodriguez-Pinto I.; Knight J.S.; Atsumi T.; Willis R.; Gonzalez E.; Lopez-Pedrera R.; Rossi Gandara A.P.; Borges Gualhardo Vendramini M.; Banzato A.; Sevim E.; Barbhaiya M.; Efthymiou M.; Mackie I.; Bertolaccini M.L.; Andrade D. |
11 | The adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction | 2017 | Radin, Massimo; Schreiber, K.; Costanzo, P.; Cecchi, I.; Roccatello, Dario; Baldovino, Simone; Bazzan, M.; Cuadrado, M. J.; Sciascia, Savino |
12 | An agent-to-agent real life comparison study of tocilizumab versus abatacept in giant cell arteritis | 2021 | Rossi, Daniela; Cecchi, Irene; Sciascia, Savino; Naretto, Carla; Alpa, Mirella; Roccatello, Dario |
13 | Allergy to buckwheat: an emerging clinical problem. Clinical and laboratory analysis of 24 consecutive patients | 2009 | Heffler, E; Asero, R; Nebiolo, F; Pizzimenti, S; Sciascia, S; Badiu, I; Guida, G; Mistrello, G; Amato, S; Marchese, C; Rolla, G |
14 | Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis | 2020 | Sciascia S.; Radin M.; Cecchi I.; Fenoglio R.; De Marchi A.; Besso L.; Baldovino S.; Rossi D.; Miraglia P.; Rubini E.; Roccatello D. |
15 | Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review. | 2013 | Sciascia S;Sanna G;Murru V;Roccatello D;Khamashta MA;Bertolaccini ML |
16 | Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection | 2020 | Trunfio mattia, Salvador elena, Cabodi daniela, Marinaro Letizia, Alcantarini chiara, Gaviraghi Alberto, Trentalange Alice, Lipani Filippo, Sciascia Savino, Roccatello Dario, Bonora Stefano, Di Perri Giovanni, Calcagno Andrea |
17 | Antibodies to phosphatidylserine/prothrombin complex and the antiphospholipid syndrome | 2014 | Sciascia, S.; Bertolaccini, M.L. |
18 | Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab | 2018 | Sciascia, Savino*; Rubini, Elena; Radin, Massimo; Cecchi, Irene; Rossi, Daniela; Roccatello, Dario |
19 | Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: A multicentre cohort study | 2019 | Sciascia, Savino; Yazdany, Jinoos; Dall'Era, Maria; Fenoglio, Roberta; Radin, Massimo; Aggarwal, Ishita; Cuadrado, Maria J.; Schreiber, Karen; Barreca, Antonella; Papotti, Mauro; Roccatello, Dario |
20 | Antiphosphatidylserine/prothrombin antibodies in systemic lupus erythematosus. | 2013 | Bertolaccini ML;Sciascia S;Sanna G;Khamashta MA |